In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
CVE-2026-44009 (CVSS score: 9.8) - A vulnerability that allows sandbox escape via a null proto exception and permits an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results